My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 92

    1.

    Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.

    Kuniholm MH, Lesi OA, Mendy M, Akano AO, Sam O, Hall AJ, Whittle H, Bah E, Goedert JJ, Hainaut P, Kirk GD.

    Environ Health Perspect. 2008 Nov;116(11):1553-7. Epub 2008 Jul 10.PMID: 19057710 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.

    Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R, Wild CP.

    Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):373-9.PMID: 15734960 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.

    Kirk GD, Lesi OA, Mendy M, Szymañska K, Whittle H, Goedert JJ, Hainaut P, Montesano R.

    Oncogene. 2005 Sep 1;24(38):5858-67.PMID: 16007211 [PubMed - indexed for MEDLINE]Related articles

    4.

    Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.

    Lleonart ME, Kirk GD, Villar S, Lesi OA, Dasgupta A, Goedert JJ, Mendy M, Hollstein MC, Montesano R, Groopman JD, Hainaut P, Friesen MD.

    Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2956-62.PMID: 16365016 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

    Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R, et al.

    Ann Intern Med. 1992 Jan 15;116(2):97-102.PMID: 1309286 [PubMed - indexed for MEDLINE]Related articles

    6.

    Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.

    Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, Wu WP, Wang LW, Wang Q, Huang GT, Yang PM, Lee HS, Santella RM.

    Int J Cancer. 1996 Sep 4;67(5):620-5.PMID: 8782648 [PubMed - indexed for MEDLINE]Related articles

    7.

    A cross sectional study of hepatitis B, C, some trace elements, heavy metals, aflatoxin B1 and schistosomiasis in a rural population, Egypt.

    Sayed HA, El Ayyat A, El Dusoki H, Zoheiry M, Mohamed S, Hassan M, El Assaly N, Awad A, El Ansary M, Saad A, El Karim AA.

    J Egypt Public Health Assoc. 2005;80(3-4):355-88.PMID: 16900614 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.

    Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Montesano R, Wild CP.

    Cancer Epidemiol Biomarkers Prev. 1992 Mar-Apr;1(3):221-7.PMID: 1339082 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

    Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A.

    Cancer. 1994 Nov 1;74(9):2442-8.PMID: 7922998 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.

    Resnick RH, Koff R.

    Arch Intern Med. 1993 Jul 26;153(14):1672-7.PMID: 7687423 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.

    Cancer. 1999 May 15;85(10):2132-7.PMID: 10326690 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.

    Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Tsai JH.

    J Med Virol. 1993 Dec;41(4):296-300.PMID: 7508973 [PubMed - indexed for MEDLINE]Related articles

    13.

    Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan.

    Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DM, Santella RM.

    Carcinogenesis. 2001 Aug;22(8):1289-94.PMID: 11470760 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.

    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.

    J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. Epub 2007 Jun 7.PMID: 17559381 [PubMed - indexed for MEDLINE]Related articles

    15.

    Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa.

    Wojnowski L, Turner PC, Pedersen B, Hustert E, Brockmöller J, Mendy M, Whittle HC, Kirk G, Wild CP.

    Pharmacogenetics. 2004 Oct;14(10):691-700.PMID: 15454734 [PubMed - indexed for MEDLINE]Related articles

    16.

    The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.

    Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R.

    Hepatology. 2004 Jan;39(1):211-9.PMID: 14752840 [PubMed - indexed for MEDLINE]Related articles

    17.

    Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

    Bird SM, Goldberg DJ, Hutchinson SJ.

    J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.PMID: 11437088 [PubMed - indexed for MEDLINE]Related articles

    18.

    A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

    Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

    Int J Epidemiol. 1998 Aug;27(4):574-8.PMID: 9758109 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.

    Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E.

    J Natl Cancer Inst. 1992 Nov 4;84(21):1638-41.PMID: 1279184 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.

    Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Liaw YF.

    Am J Epidemiol. 1997 Jun 1;145(11):1039-47.PMID: 9169913 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity